Mobilization of iron from coal fly ash was dependent upon the particle size and the source of coal

Particulate air pollution, including coal fly ash, contains iron, and some of the pathological effects after inhalation may be due to reactive oxygen species produced by iron-catalyzed reactions. The objective of this study was to determine whether iron, present in coal fly ash, was mobilized, leading to ferritin induction in human airway epithelial cells, and whether the size of the particles affected the amount of iron mobilized. Three types of coal were used to generate the three size fractions of fly ash collected. The Utah coal fly ash was generated from a bituminous b coal, the Illinois coal fly ash from a bituminous c coal, and the North Dakota coal fly ash from a lignite a coal. Three size fractions were studied to compare the amount of iron mobilized in human airway epithelial (A549) cells and by citrate in cell-free suspensions. The size fractions selected were fine (<2.5 microm) and coarse (2.5-10 microm) components of PM10, airborne particulate matter <10 microm in diameter, and the fraction greater than 10 microm. Coal fly ash samples were incubated with 1 mM citrate to determine if iron associated with coal fly ash could be mobilized. Iron was mobilized by citrate from all three size fractions of all three coal types to levels as high as 56.7 nmol of Fe/mg of coal fly ash after 24 h. With all three coal types, more iron was mobilized by citrate from the <2.5 microm fraction than from the >2.5 microm fractions. Further, the mobilized iron was in the Fe(III) form. To determine if iron associated with the coal fly ash could be mobilized by A549 cells, cells were treated with coal fly ash, and the amount of the iron storage protein ferritin was determined after 24 h. Ferritin levels were increased by as much as 11.9-fold in cells treated with coal fly ash. With two of the three types of coal studied, more ferritin was induced in cells treated with the <2.5 microm fraction than with the >2.5 microm fractions. Further, inhibition of the endocytosis of the coal fly ash by the cells resulted in ferritin levels that were near that of the untreated cells, suggesting that iron was mobilized intracellularly, not in the culture medium. The results of this study suggest that differences in particle size and speciation of iron may affect the release of iron in human airway epithelial cells.     

DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate

The purpose of the present study was to evaluate in a novel manner the arsenic exposure of humans living in two towns in Northeastern Chile. Residents of one town drink water containing 593 microg As/l. Those in the control town drink water containing 21 microg As/l. Our hypothesis was that the administration of the chelating agent, 2,3-dimercaptopropane-1-sulfonic acid, Na salt (DMPS, DIMAVAL) would increase the urinary excretion of arsenic, alter the urinary profile of arsenic species and thus result in a better indication of the body load of arsenic and a better biomarker for arsenic exposure. The method used to evaluate these subjects was to give them 300 mg DMPS by mouth, after an overnight fast, and collect urine at specified time periods. The urine samples were analyzed for inorganic arsenic, monomethylarsonic acid (MMA), dimethylarsinic acid (DMA) and total arsenic by hydride generation and atomic absorption spectrophotometry. The results indicated that: 1) During the 2-hr period after DMPS administration, MMA represented 42%, inorganic As, 20 to 22% and DMA, 37 to 38% of the total urinary arsenic. The usual range of the MMA percentage in human urine has been 10 to 20%. The % MMA increased almost equally for both the arsenic-exposed and control subjects. 2) The exposed subjects had a greater urinary excretion of total arsenic, before and after DMPS administration, than the control subjects. 3) Although buccal cells were obtained only from a few subjects, the prevalence of mononucleated buccal cells, an indication of genotoxicity, was 5-fold greater for those who consumed drinking water with the higher arsenic content than among control subjects. Our conclusions are that 1) DMPS has a highly specific effect in humans on MMA metabolism and/or urinary excretion; 2) the human body stores substantial amounts of arsenic; and 3) the urinary arsenic concentration after DMPS administration may be more indicative of the body burden of arsenic because it was greater than that found before DMPS was given.     

Chrono-neuroendocrine markers of the aging brain

OBJECTIVE: This Belgian study assessed the geographical and temporal differences in the exposure of the population to inorganic arsenic, a known carcinogen. METHODS: In the CadmiBel study (1985-9) the 24 h urinary arsenic excretion was measured, as an index of recent exposure, in industrialised cities (Liège: n = 664, Charleroi: n = 291), in a rural control area (Hechtel-Eksel: n = 397), and in rural districts in which the population had possibly been exposed through the drinking water or the emissions of nonferrous smelters (Wezel: n = 93, Lommel: n = 111, and Pelt: n = 133). In the PheeCad study, in 1991-5, the rural areas (n = 609) were re-examined together with an urban control area (Leuven: n = 152). RESULTS: The CadmiBel results showed that after adjustment for sex, age, and body mass index, the 24 h arsenic excretion was on average low in Liège (91 nmol), Charleroi (155 nmol), Hechtel-Eksel (144 nmol), and Wezel (158 nmol), whereas the highest excretions were found in Lommel (570 nmol) and Pelt (373 nmol). During the PheeCad study, the mean 24 h arsenic excretion in the rural areas ranged from 81 to 111 nmol. This was lower than six years earlier and similar to the excretion in the control town (108 nmol). Longitudinal studies in 529 people living in the rural areas confirmed that their 24 h arsenic excretion had decreased (P < 0.001) from 222 to 100 nmol. As well as the drinking water, industry was likely to be a source of the increased exposure in Lommel and Pelt in 1985-9, because at that time the urinary arsenic excretion did not follow the regional differences in the arsenic content of the drinking water, because the fall in the arsenic excretion over time coincided with the implementation by industry of stricter environmental regulations, because in individual subjects the urinary arsenic excretion was inversely correlated with the distance to the nearest smelter, and because an increased arsenic excretion was only found downwind from the main smelter. The official network that monitors the arsenic concentration in airborne and fall out dust did not detect the high exposure in Lommel and Pelt between 1985 and 1989. CONCLUSION: This study highlights the necessity to validate environmental monitoring programmes by directly estimating the internal exposure of the population.     

Urinary N-acetyl-beta-glucosaminidase as an indicator of renal dysfunction in electroplating workers

OBJECTIVES: To investigate chromium-induced renal dysfunction in electroplating workers. METHODS: A cross-sectional study was used to evaluate four biochemical markers of renal function. A total of 178 workers were divided into 3 comparable groups consisting of 34 hard-chrome plating workers, 98 nickel-chrome electroplating workers. and 46 aluminum anode-oxidation workers, who represented the reference group. Ambient and biological monitoring of urinary chromium were performed to measure exposure concentrations. RESULTS: Overall, urinary chromium concentrations were highest among hard-chrome plating workers (geometric mean 2.44 microg/g creatinine), followed by nickel-chrome electroplating workers (0.31 microg/g creatinine) and aluminum workers (0.09 microg/g creatinine). Airborne chromium concentrations were also highest in the hard-chrome plating area (geometric mean 4.20 microg/m3), followed by the nickel-chrome electroplating area (0.58 microg/m3) and the aluminum area (0.43 microg/m3). A positive correlation was found between urinary chromium and airborne concentrations (r=0.54, P < 0.01). Urinary concentrations of N-acetyl-beta-D-glucosaminidase (NAG) were also highest among hard-chrome plating workers (geometric mean 4.9 IU/g creatinine), followed by nickel-chrome workers (3.4 IU/g creatinine) and aluminum workers (2.9 IU/g creatinine). The prevalence of "elevated" NAG (>7 IU/g creatinine) was significantly highest among hard-chrome plating workers (23.5%), then among nickel-chrome workers (7.1%) and aluminum workers (8.7%). Differences in beta2-microglobulin, total protein, and microalbumin were not significant. CONCLUSION: The author's evidence indicates that NAG is an early indicator of renal dysfunction in hard-chrome plating workers.     

Speciation of arsenic metabolites in the urine of occupational workers and experimental rats using an optimised hydride cold-trapping method

A hydride cold-trapping technique was developed and optimised for the measurement of urinary arsenic metabolites. The analytical precision of the method was found to be 6.1, 4.0 and 4.8% (n = 5) for inorganic arsenic (ASi), monomethylarsonate (MMA) and dimethylarsinate (DMA), respectively, with recoveries close to 100%. The detection limits were 1.0, 1.3 and 3 ng for ASi, MMA and DMA, respectively. The method was then used to analyse urine samples obtained from three groups of workers for occupational exposure in three companies where copper chrome arsenate was used for timber treatment. The results were compared with those for a normal control group of laboratory workers. Arsenic and its metabolites were also measured in experimental rats given 5 mg As kg-1 body mass by oral gavage in the form of sodium arsenite, calcium arsenite or sodium arsenate. Occupational workers showed a significantly higher excretion of ASi. Up to two fold increases of urinary ASi excretion in rats compared with control rats were also observed in animals dosed with various forms of arsenicals. The method is suitable for the measurement of arsenic metabolites in urine of both humans and experimental animals.     

The circadian variation of urinary N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transpeptidase in clinically healthy cats

The circadian variation of urinary N-acetyl-beta-D-glucosaminidase (NAG, EC 3.2.1.30) and gamma-glutamyl transpeptidase (gamma-GTP, EC 2.3.2.2) was evaluated in cats. Urine and blood were collected at 4-hr intervals from adult cats (3 males, 9 females) weighing between 2.6 and 5.0 kg. There was no circadian variation in the urine volume, creatinine clearance, creatinine excretion, NAG excretion or gamma-GTP excretion. The average NAG and gamma-GTP indices in the 4-hr urine were similar to those for the 24-hr urine. However, the variance for the 4-hr urine samples was higher than that of 24-hr urine. In conclusion, although 4-hr urine samples can be used to estimate 24-hr urinary enzyme excretion, short-term spot urine samples may cause increased variation in the enzyme index.     

Arsenic trioxide absorption and excretion in industry

1. A study of 24 smelter workers routinely exposed to arsenic trioxide was conducted to evaluate some characteristics of its absorption and excretion. A statistically significant correlation was found between airborne arsenic trioxide concentrations below 300 mug/m3 and urinary arsenic values below 500 mug/liter. These men wore personal monitors for five consecutive work days and were determined to have been exposed to average airborne arsenic concentrations of 53 mug/m3 (70 mug/m3 of arsenic trioxide) which increased their urinary arsenic values from 152 mug/liter to 200 mug/liter (an average gain on 32%). 2. The background average urinary arsenic value for adult males not exposed to arsenic trioxide in industry was determined to be 52.6 mug/liter for 204 men during preemployment examinations. 3. After removal from industrial arsenic trioxide exposure, the rate of fall in urinary arsenic values varies with the magnitude of the urinary arsenic level. An initial decrease of 9.5% per day was measured for workers having urinary arsenic values below 200 mug/liter. The initial decrease is about 21% per day for workers with urinary arsenic values over 600 mug/liter. 4. It was determined that arsenic in seafood can alter, in a dramatic fashion, the urinary arsenic values determined for smelter workers within 24 hours following consumption. It is recommended, therefore, that the absorption of arsenic trioxide due to industrial exposure is best evaluated from urine samples collected at least two days after seafood has been eaten.     

超声提取—顺序注射氢化物发生-原子荧光光谱法测定煤中无机砷

利用6 mol/L盐酸作为提取试剂,样品经超声提取后,用顺序注射氢化物发生-原子荧光光谱法测定煤中无机砷的含量。对超声提取条件(提取试剂浓度、时间、温度)进行了优化。在优化的实验条件下,砷的浓度在0.20～100 μg/L范围内与荧光强度呈线性关系,相关系数为0.999 7,砷的检出限为0.025 μg/L,对10 μg/L砷标准溶液进行重复11次测量 , 得出相对标准偏差(RSD)为0.9 %。用该法对煤飞灰成分分析标准物质GBW08401和煤样进行分析,测得回收率在95%～102%之间,标准样品的测定值和认定值相符。     

Probenecid protects against In vivo acetaminophen-induced nephrotoxicity in male Wistar rats

Renal effects of acetaminophen (APAP) were studied in rats pretreated with probenecid to analyze whether acute APAP-induced nephrotoxicity could be related to a probenecid-sensitive transport system for APAP or its S-derived conjugates. The administration of probenecid (200 mg/kg b.wt. i.p.) 30 min before APAP administration (1000 mg/kg b.wt. i.p.) improved urine flow rate and protected against the alterations on glomerular filtration rate and urea and creatinine plasma levels induced by APAP. Fewer epithelial cells and granular casts and a decrease in the urinary excretion of protein and glucose were observed in rats pretreated with probenecid. Probenecid pretreatment promoted an elevation in the urinary 16-hr excretion of APAP and a diminution in the plasma levels attained by APAP. These results suggest that protection afforded by probenecid in vivo could be a consequence of the inhibition of APAP S-conjugate renal uptake and/or an increase in APAP renal clearance. The effects of APAP in presence of probenecid were studied with the isolated perfused kidney model. Perfusion with probenecid (0.1 mM) before APAP (10 mM) did not change APAP direct renal effects, APAP urinary excretion, or APAP renal clearance relative to glomerular filtration rate. Our results suggest that protection afforded by probenecid in vivo could be the result of the inhibition of the uptake of nephrotoxic APAP metabolites and/or a diuresis-induced enhanced APAP renal excretion.     

Urinary excretion of nitric oxide metabolites in runners, sedentary individuals and patients with coronary artery disease: effects of 42 km marathon, 15 km race and a cardiac rehabilitation program

BACKGROUND: The mechanisms by which regular exercise is associated with decreases in all-cause and cardiovascular mortality are unknown. Nitric oxide (NO) may have a role, as it is known to be an important factor in cardiovascular regulation. The relationships between physical activity and systemic formation of NO were evaluated in healthy volunteers and in patients with coronary artery disease (CAD). METHODS: Urinary excretion of NO metabolites (nitrates + nitrites) was measured in 50 men. Group 1 comprised 14 highly trained runners (90 km/week) who were tested before and after a marathon race of 42.2 km. Group 2 comprised 11 well trained men (64 km/week) who were tested before and after a 15 km race. Group 3 comprised 12 sedentary individuals who gave a single urine sample. Group 4 comprised 13 patients with CAD who were tested before and after a 6 km walk. RESULTS: Group 1 showed the highest basal levels of urinary NO metabolites: 10.10 mmol/g creatinine; they were followed by group 2, with 5.60 mmol/g creatinine, group 3 with 1.59 mmol/g creatinine and patients with CAD (group 4), who had 0.35 mmol/g creatinine. After the marathon, those in group 1 showed a significant (P=0.0001) reduction of 80% in the excretion of NO metabolites. The 15 km race (group 2 and the 6 km walk (group 4), produced nonsignificant reductions in NO excretion. Patients with CAD were prospectively evaluated before and after a 12-week cardiac rehabilitation program. Their urinary excretion of NO metabolites (mmol/g creatinine) at the end of the program was 157% higher than at baseline (P=0.034). A positive, significant correlation (P=0.006) was observed between the increases in exercise capacity [in METs (one MET is equal to the body's oxygen consumption at rest, and corresponds to 3.5 ml/Kg/min)] and in NO metabolite excretion induced by the 12-week program. CONCLUSIONS: The baseline urinary excretion of NO metabolites increases with increasing levels of physical activity (chronic aerobic exercise). Patients with CAD had lowest levels of urinary NO metabolites and these increased in direct proportion with the gain in functional capacity. These findings suggest that increased NO production may be a major adaptive mechanism by which chronic aerobic exercise training benefits the cardiovascular system. The marked increase in NO production induced by long-term, high levels of aerobic exercise may be protective in athletes undertaking strenuous levels of exercise.     

Human leucocyte antigen-DQA1, -DQB1 polymorphism distribution in Shanghai Chinese women with pregnancy induced hypertension]

Our objective was to determine if maternal urinary calcium excretion is altered during treatment of mild preeclampsia remote from term with the calcium channel blocker nifedipine. One hundred forty-eight women with mild preeclampsia were randomly allocated to treatment with either bed rest alone (n=64) or in combination with nifedipine (n=84) at 26-36 weeks' gestation. All women had 24 hr urine samples collected for creatinine clearance and calcium excretion determination prior to therapy and during treatment. There was no difference in gestational age at the time of urine collection between the two groups. There were no differences in 24-hr creatinine clearance and calcium excretion between the groups prior to therapy. When followed longitudinally, there was a significant reduction in calcium excretion within each group (p=0.0005 control group, p <0.0001 nifedipine group). Further, a significant reduction in calcium excretion was noted following nifedipine therapy (62+/-94 mg Ca/24 hr) compared to the control group (143+/-153 mg Ca/24 hr), p <0.001. Consistent with previous studies, we have shown that progressive hypocalciuria is a feature of preeclampsia. Further, urinary calcium excretion decreased despite nifedipine therapy. Altered urinary calcium excretion may be less reflective of the progression in severity of preeclampsia in patients treated with nifedipine.     

Metabolic interferences in subjects occupationally exposed to binary styrene-acetone mixtures

OBJECTIVE: To investigate the excretion of styrene metabolites (mandelic acid, MA, and phenylglyoxylic acid, PGA) in workers employed in plastic manufacturing to verify the possible influence of coexposure to acetone on styrene metabolism. METHODS: This study was carried out on 50 workers employed in 3 factories producing polyester buttons. The workers were divided into three groups according to three different levels of acetone exposure. The trend of excretion for metabolites was examined during and after work shifts. Styrene and acetone were monitored on Thursday during the entire work shift by passive dosimeters placed on the lapel of the workers' uniforms, desorbed by carbon disulfide, and analyzed by gas chromatography. Biological monitoring was performed by determination of the urinary metabolites of styrene in urine samples collected on Thursday at the middle and the end of the work shift. MA and PGA were determined by a high-pressure liquid chromatographic method. RESULTS: The styrene concentrations ranged between 16 and 439 mg/m3, and in ten samples they exceeded the TLV-TWA (213 mg/m3). The acetone concentration ranged between 15 and 700 mg/m3 (TLV-TWA 1780 mg/m3), with the mean value being 208 mg/m3. During cleaning operations higher exposures to acetone demonstrated, with concentrations ranging between 500 and 3400 mg/m3. The amounts of MA and PGA determined at the end of workshifts did not significantly differ between the groups with different levels of acetone coexposure. Analysis of variance (ANOVA) between the groups confirmed that MA and PGA excretion did not significantly differ, although the metabolite values measured on the "morning of the day after" appeared higher in those groups with high levels of acetone exposure and were related to the average airborne concentrations of the solvent. In addition, the range and degree of correlation between styrene in air and biological levels of metabolites were modified by coexposure to acetone. CONCLUSIONS: Our data demonstrate that amounts of MA and PGA did not differ in groups with different levels of acetone exposure, but when the acetone air concentration increased the degree of correlation between styrene and MA and PGA decreased. Furthermore, coexposure to acetone levels similar to those described herein may hamper the use of urinary metabolites for the assessment of exposure to styrene, especially on an individual basis.     

Religiosity as a protective or prognostic factor of depression in later life; results from a community survey in The Netherlands

OBJECTIVES: This study explored the possibility of using urinary 1-naphthol excretion as a marker of complex exposure among workers handling creosote. METHODS: Urine specimens of 6 workers from a creosote impregnation plant, where railroad ties were impreganted with coal tar creosote, were collected during 1 workweek, and the concentration of 1-naphthol was determined. 1-Naphthol in spot urine samples of 5 occupationally nonexposed male smokers was used as the background reference. Concurrently, naphthalene and 10 different polycyclic aromatic hydrocarbons (PAH) were determined in personal air samples. RESULTS: The mean airborne exposure of the workers was 1.5 mg/m3 for vaporous naphthalene, 5.9 micrograms/m3 for particulate PAH and 1.4 micrograms/m3 for PAH with 4-6 aromatic rings. The mean urinary concentration of 1-naphthol at the end of the workshift was 20.5 (range 3.5-62.1) mumol/l, whereas the referents' urinary concentration was below the detection limit (0.07 mumol/l). Airborne naphthalene correlated fairly well with 1-naphthol when measured at the end of the shift (r = 0.745). CONCLUSIONS: This method of analysis for 1-naphthol is sufficiently sensitive for measuring low occupational exposures to naphthalene. Low background exposures are, however, unlikely to result in detectable urinary levels of 1-naphthol. Since naphthalene is the most abundant compound in creosote vapor, urinary 1-naphthol determination serves well as a biological marker of exposure to vaporous creosote. Urinary 1-naphthol alone is not, however, a suitable marker for inhalatory or cutaneous exposure to PAH originating from creosote.     

Forefront of lung cancer therapy

The differential urinary excretion of orally administered lactulose and mannitol is used to evaluate intestinal permeability. This test usually involves a 5- to 6-hr urine collection. We hypothesized that a shorter collection time would give an equivalent result. Forty-three patients with a variety of gastrointestinal symptoms and diagnoses (group 1) and 42 patients with Crohn's disease (group 2) had a standard lactulose/mannitol permeability test. The lactulose and mannitol urinary excretion was calculated using the first urine (group 1) or the 1-hr and 2-hr urine (group 2) and was compared to the values calculated from the routine 5- or 6-hr collection. Lactulose excretion kinetics, expressed as the percent of the total urinary excretion within a given time period, were as follows: 21% in first hour (group 2), 29% in second hour (group 2), and 46% in first 2.5 hr (group 1). Mannitol urinary excretion kinetics were 16%, 31%, and 44%, respectively. The lactulose/mannitol ratio based on a standard urine collection correlated well with the ratio based on just the first urine produced by the patient (R2 = 0.94; P < 0.001; group 1) and the 2-hr urine (R2 = 0.464; P < 0.001; group 2). Future use of the lactulose/mannitol ratio to assess intestinal permeability may be able to be simplified by shortening the urine collection time.     

微波消解-电感耦合等离子体质谱法测定粉煤灰中铀

粉煤灰是一种宝贵的铀资源,为了满足我国日益增长的核电对铀的需求,必须加大对粉煤灰中铀的综合回收利用,因此准确测定粉煤灰中铀含量意义重大。采用HNO₃-HF-HClO₄体系微波消解样品,选择¹⁸⁷Re为内标元素,²³⁸U为铀测定同位素,建立了微波消解-电感耦合等离子体质谱法(ICP-MS)准确快速测定粉煤灰中铀的分析方法。对溶样条件进行了优化,确定溶样酸用量为5.0mL HNO₃、3.0mL HF、0.50mL HClO₄,消解程序如下所示:消解功率为800W,15min从室温升到150℃,保温10min,15min从150℃升到200℃,保温30min。实验表明,当铀的质量浓度范围为0.5~20ng/mL时,铀的质量浓度与其对应的信号强度呈线性关系,线性相关系数为0.9999,方法检出限为0.05μg/g。将实验方法应用于粉煤灰实际样品分析,测定结果的相对标准偏差(RSD,n=6)为3.2%,加标回收率为95%~104%。选取来自不同地方燃煤电厂的粉煤灰,按照实验方法进行铀的测定,并与激光荧光法进行对比,两种方法测定结果基本一致。     

含砷铁矿石烧结及除尘灰焙烧脱砷热力学

 为了研究铁矿石烧结及除尘灰焙烧脱砷问题,运用FactSage软件研究了不同氧分压、温度及碱度对含砷铁矿石烧结脱砷率、砷平衡组成、脱砷最终形态的影响,并对除尘灰焙烧脱砷流程进行热力学研究。结合烧结杯进行烧结试验,并在多气氛下利用焙烧除尘灰试验进行验证,运用XRD、SEM及EDS对矿相进行分析。结果表明,脱砷产物及脱砷率与温度、氧分压及碱度密切相关。在烧结过程中,残留在烧结矿中的砷,主要是固态砷酸盐,其他砷会以As4O6（g）等气态物质脱除。除尘灰中砷以固态As2O3（s）和As2O5（s）存在。在空气或厌氧气氛下焙烧除尘灰,会使砷转变为砷酸盐。但采用配比煤粉及厌氧条件下,在600 ℃以上焙烧除尘灰,可使砷以气态As4（g）挥发,在400 ℃以下析出单质砷。     

Feasibility of Using Coal Fly Ash for Mine Waste Containment

This study investigates the feasibility of using coal fly ash and fly ash-bentonite mixtures as a barrier material for mine waste. The hydraulic conductivity of the coal fly ash was measured to be in the order of 2×10?9?m/s when it was permeated with deionized water, and this value decreased significantly when the permeant was switched to acid mine drainage (AMD). The addition of bentonite to coal fly ash lowered the hydraulic conductivity during water permeation but no further significant change was observed upon switching the permeant to AMD. Chemical analyses on the effluent from the hydraulic conductivity tests indicated that heavy metals present in AMD were attenuated and were well below the leachate criteria set by the Ontario Government. X-ray diffraction and scanning electron microscopy analyses results of postpermeation samples showed significant structural differences and formation of secondary minerals after AMD permeation. The results of this study suggest that the addition of 10% bentonite to coal fly ash reduced the hydraulic conductivity of the coal fly ash to less than 1×10?9?m/s and improved the chemical compatibility for mine waste containment.     

高炉喷吹垃圾焚烧飞灰预处理工艺分析

为了解决高炉协同处置垃圾焚烧飞灰时氯负荷高的问题,以去离子水作为洗脱剂,通过考查不同水洗条件(水灰比、水洗时间、水洗温度、水洗次数)下垃圾焚烧飞灰中Cl元素和重金属元素的脱除效果,对飞灰高炉焚烧固化预处理中的工艺参数进行研究。结果表明,飞灰中Cl主要以NaCl、KCl、CaClOH的形式存在。在高炉协同处理前水洗预处理的适宜条件为水灰比为4 ml/g、水洗时间为5 min、水洗温度为25℃、水洗1次。在此条件下飞灰中Cl脱除率为86.45%、Zn脱除率为4.77%、Pb脱除率为35.65%、Cu脱除率为7.63%、Cr脱除率为9.71%。水洗后飞灰的配加比例、单位时间喷吹量、喷吹速度需按企业自身情况确定。在高炉喷煤比为139.12 kg/t(Fe)和飞灰喷吹量为喷煤量的1%条件下,由水洗后飞灰带入高炉的Cl质量为0.078 kg/t(Fe)、Zn为9.74×10^-3 kg/t(Fe)、Pb为1.53×10^-3 kg/t(Fe)、Cu为8.35×10^-4 kg/t(Fe)、Cr为9.88×10^-5 k...     

高炉喷吹垃圾焚烧飞灰预处理工艺分析

为了解决高炉协同处置垃圾焚烧飞灰时氯负荷高的问题,以去离子水作为洗脱剂,通过考查不同水洗条件(水灰比、水洗时间、水洗温度、水洗次数)下垃圾焚烧飞灰中Cl元素和重金属元素的脱除效果,对飞灰高炉焚烧固化预处理中的工艺参数进行研究。结果表明,飞灰中Cl主要以NaCl、KCl、CaClOH的形式存在。在高炉协同处理前水洗预处理的适宜条件为水灰比为4 ml/g、水洗时间为5 min、水洗温度为25 ℃、水洗1次。在此条件下飞灰中Cl脱除率为86.45%、Zn脱除率为4.77%、Pb脱除率为35.65%、Cu脱除率为7.63%、Cr脱除率为9.71%。水洗后飞灰的配加比例、单位时间喷吹量、喷吹速度需按企业自身情况确定。在高炉喷煤比为139.12 kg/t(Fe)和飞灰喷吹量为喷煤量的1%条件下,由水洗后飞灰带入高炉的Cl质量为0.078 kg/t(Fe)、Zn为9.74×10-3 kg/t(Fe)、Pb为1.53×10-3 kg/t(Fe)、Cu为8.35×10-4 kg/t(Fe)、Cr为9.88×10-5 kg/t(Fe),远低于一般高炉熔炼要求,可以满足高炉正常运行需求。     

Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar

A group of eczema patients topically treated with coal tar (CT) ointments was used as a model population to examine the applicability of DNA adducts in WBC subpopulations as a measure of dermal exposure to polycyclic aromatic hydrocarbons (PAHs). Aromatic DNA adducts were examined by 32P-postlabeling in exposed skin and WBC subsets, and urinary excretion of PAH metabolites was determined to assess the whole-body burden. The median urinary excretion of 1-hydroxypyrene and 3-hydroxybenzo(a)pyrene was 0.39 (range, 0.12-1.57 micromol/mol creatinine) and 0.01 micromol/mol creatinine (range, <0.01-0.04 micromol/mol creatinine), respectively, before the dermal application of CT ointments. After treatment for 1 week, these levels increased to 139.7 (range, 26.0-510.5 micromol/mol creatinine) and 1.18 micromol/mol creatinine (range, <0.01-2.14 micromol/mol creatinine), respectively, indicating that considerable amounts of PAHs were absorbed. Median aromatic DNA adduct levels were significantly increased in skin from 2.9 adducts/10(8) nucleotides (nt; range, 0.7-10.0 adducts/10(8) nt) before treatment to 63.3 adducts/10(8) nt (range, 10.9-276.2 adducts/10(8) nt) after treatment with CT, in monocytes from 0.28 (range, 0.25-0.81 adducts/10(8) nt) to 0.86 adducts/10(8) nt (range, 0.56-1.90 adducts/10(8) nt), in lymphocytes from 0.33 (range, 0.25-0.89 adducts/10(8) nt) to 0.89 adducts/10(8) nt (range, 0.25-3.01 adducts/10(8) nt), and in granulocytes from 0.28 (range, 0.25-0.67 adducts/10(8) nt) to 0.54 adducts/10(8) nt (range, 0.25-1.58 adducts/10(8) nt). A week after stopping the CT treatment, the DNA adduct levels in monocytes and granulocytes were reduced to 0.38 (range, 0.25-0.71 adducts/10(8) nt) and 0.38 adducts/10(8) nt (range, 0.25-1.01 adducts/10(8) nt), respectively, whereas the adduct levels in lymphocytes remained enhanced [1.59 adducts/10(8) nt (range, 0.25-2.40 adducts/10(8) nt)]. Although the adduct profiles in skin and WBC subsets were not identical, and the adduct levels in WBCs were significantly lower as compared with those in skin, the total DNA adduct levels in skin correlated significantly with the adduct levels in monocytes and lymphocytes, but not with those in granulocytes. Excretion of urinary metabolites during the first week of treatment was correlated with the percentage of the skin surface treated with CT ointment and decreased to background levels within a week after the cessation of treatment. 3-Hydroxybenzo(a)pyrene excretion, but not that of 1-hydroxypyrene, correlated significantly with the levels of DNA adducts in skin that comigrated with benzo(a)pyrene-diol-epoxide-DNA. This study indicates that the DNA adduct levels in mononuclear WBCs can possibly be used as a surrogate for skin DNA after dermal exposure to PAHs.